Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim Meyer

Showing results (431-440 of 510) with videos related to

Pageof 51
Sort By:
Hepatology Communications|March 8, 2021
A Real-World Observational Cohort of Patients with Hepatocellular Carcinoma: Design and Rationale for TARGET-HCCRoniel Cabrera, Amit G Singal, Massimo Colombo, et al.
British Journal of Cancer|June 4, 2026
A first-in-human, open-label multicentre Phase 1 study of the orally administered E7386 in patients with selected advanced neoplasmsT R Jeffry Evans, Natalie Cook, Anthony El-Khoueiry, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 28, 2013
Transarterial embolization as neo-adjuvant therapy pretransplantation in patients with hepatocellular carcinomaEmmanuel Tsochatzis, Matteo Garcovich, Laura Marelli, et al.
Endocrine-Related Cancer|July 19, 2021
Whole-genome sequencing of single circulating tumor cells from neuroendocrine neoplasmsAlexa Childs, Christopher D Steele, Clare Vesely, et al.
Liver Cancer|August 8, 2024
A Phase 1b Study of Lenvatinib plus Pembrolizumab in Patients with Unresectable Hepatocellular Carcinoma: Extended Analysis of Study 116Masatoshi Kudo, Richard S Finn, Masafumi Ikeda, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 31, 2025
Nivolumab With or Without Ipilimumab in Patients With Recurrent or Metastatic Merkel Cell Carcinoma: A Nonrandomized, Open-Label, International, Multicenter Phase I/II StudyShailender Bhatia, Suzanne L Topalian, William Sharfman, et al.
Endocrine-Related Cancer|April 23, 2015
Epigenetic dysregulation and poorer prognosis in DAXX-deficient pancreatic neuroendocrine tumoursChristodoulos P Pipinikas, Harpreet Dibra, Anna Karpathakis, et al.
Acta Physiologica (Oxford, England)|January 28, 2026
Functional Training Mitigates Reduced Circulating Indole-3-Lactate Levels in Persons With Relapsing-Remitting Multiple SclerosisTiffany Wences Chirino, Frederike Adammek, Sergen Belen, et al.
Nature Cardiovascular Research|April 26, 2024
Therapeutic efficacy of AAV-mediated restoration of PKP2 in arrhythmogenic cardiomyopathyEirini Kyriakopoulou, Danielle Versteeg, Hesther de Ruiter, et al.
Oncology|June 4, 2016
Enumeration and Molecular Characterisation of Circulating Tumour Cells in Endometrial CancerCharlotte R Lemech, Leah Ensell, Jennifer C Paterson, et al.
Pageof 51

Showing results (431-440 of 510) with videos related to

Sort By:
Pageof 51
Hepatology Communications|March 8, 2021
A Real-World Observational Cohort of Patients with Hepatocellular Carcinoma: Design and Rationale for TARGET-HCCRoniel Cabrera, Amit G Singal, Massimo Colombo, et al.
British Journal of Cancer|June 4, 2026
A first-in-human, open-label multicentre Phase 1 study of the orally administered E7386 in patients with selected advanced neoplasmsT R Jeffry Evans, Natalie Cook, Anthony El-Khoueiry, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 28, 2013
Transarterial embolization as neo-adjuvant therapy pretransplantation in patients with hepatocellular carcinomaEmmanuel Tsochatzis, Matteo Garcovich, Laura Marelli, et al.
Endocrine-Related Cancer|July 19, 2021
Whole-genome sequencing of single circulating tumor cells from neuroendocrine neoplasmsAlexa Childs, Christopher D Steele, Clare Vesely, et al.
Liver Cancer|August 8, 2024
A Phase 1b Study of Lenvatinib plus Pembrolizumab in Patients with Unresectable Hepatocellular Carcinoma: Extended Analysis of Study 116Masatoshi Kudo, Richard S Finn, Masafumi Ikeda, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 31, 2025
Nivolumab With or Without Ipilimumab in Patients With Recurrent or Metastatic Merkel Cell Carcinoma: A Nonrandomized, Open-Label, International, Multicenter Phase I/II StudyShailender Bhatia, Suzanne L Topalian, William Sharfman, et al.
Endocrine-Related Cancer|April 23, 2015
Epigenetic dysregulation and poorer prognosis in DAXX-deficient pancreatic neuroendocrine tumoursChristodoulos P Pipinikas, Harpreet Dibra, Anna Karpathakis, et al.
Acta Physiologica (Oxford, England)|January 28, 2026
Functional Training Mitigates Reduced Circulating Indole-3-Lactate Levels in Persons With Relapsing-Remitting Multiple SclerosisTiffany Wences Chirino, Frederike Adammek, Sergen Belen, et al.
Nature Cardiovascular Research|April 26, 2024
Therapeutic efficacy of AAV-mediated restoration of PKP2 in arrhythmogenic cardiomyopathyEirini Kyriakopoulou, Danielle Versteeg, Hesther de Ruiter, et al.
Oncology|June 4, 2016
Enumeration and Molecular Characterisation of Circulating Tumour Cells in Endometrial CancerCharlotte R Lemech, Leah Ensell, Jennifer C Paterson, et al.
Pageof 51